Search research articles
Contact Us
Filters
Showing results (31-40 of 92) with videos related to
Page
of 10
Sort By:
Annals of Internal Medicine
|
July 1, 1987
Low osmolar contrast agents and nephrotoxicity
J R Evans, S W Shankel, R E Cutler
Endocrinology
|
October 1, 1994
Delta protein kinase-C in the rat ovary: estrogen regulation and localization
R E Cutler, E T Maizels, M Hunzicker-Dunn
Journal of Clinical Pharmacology
|
November 1, 1981
Long-term bumetanide treatment of patients with edema due to renal disease. Cooperative studies
W J Stone, W M Bennett, R E Cutler
Journal of Clinical Pharmacology
|
September 1, 1988
Pharmacokinetics of iothalamate in endstage renal disease
J R Evans, R E Cutler, S C Forland
Proceedings of the Clinical Dialysis and Transplant Forum
|
January 1, 1973
Kinetics of ethambutol elimination in renal disease
T G Christopher, A Blair, A Forrey, et al.
Nephron
|
January 1, 1987
Reappraisal of femoral vein cannulation for temporary hemodialysis vascular access
A F Firek, R E Cutler, P G St John Hammond
Clinical Chemistry
|
February 1, 1974
Furosemide concentrations in serum and urine, and its binding by serum proteins as measured fluorometrically
A W Forrey, B Kimpel, A D Blair, et al.
American Journal of Clinical Pathology
|
June 1, 1980
Autosomal dominant polycystic kidney disease. Early diagnosis and consideration of pathogenesis
J Milutinovic, L C Agodoa, R E Cutler, et al.
The Journal of Antimicrobial Chemotherapy
|
November 1, 1982
Pharmacokinetics of ceftizoxime
R E Cutler, A D Blair, E D Burgess, et al.
Archives of Internal Medicine
|
March 1, 1971
Aminocaproic acid treatment of prolonged hematuria following renal biopsy
T A Haygood, R Atkins, J A Kennedy, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 92) with videos related to
Sort By:
Page
of 10
Annals of Internal Medicine
|
July 1, 1987
Low osmolar contrast agents and nephrotoxicity
J R Evans, S W Shankel, R E Cutler
Endocrinology
|
October 1, 1994
Delta protein kinase-C in the rat ovary: estrogen regulation and localization
R E Cutler, E T Maizels, M Hunzicker-Dunn
Journal of Clinical Pharmacology
|
November 1, 1981
Long-term bumetanide treatment of patients with edema due to renal disease. Cooperative studies
W J Stone, W M Bennett, R E Cutler
Journal of Clinical Pharmacology
|
September 1, 1988
Pharmacokinetics of iothalamate in endstage renal disease
J R Evans, R E Cutler, S C Forland
Proceedings of the Clinical Dialysis and Transplant Forum
|
January 1, 1973
Kinetics of ethambutol elimination in renal disease
T G Christopher, A Blair, A Forrey, et al.
Nephron
|
January 1, 1987
Reappraisal of femoral vein cannulation for temporary hemodialysis vascular access
A F Firek, R E Cutler, P G St John Hammond
Clinical Chemistry
|
February 1, 1974
Furosemide concentrations in serum and urine, and its binding by serum proteins as measured fluorometrically
A W Forrey, B Kimpel, A D Blair, et al.
American Journal of Clinical Pathology
|
June 1, 1980
Autosomal dominant polycystic kidney disease. Early diagnosis and consideration of pathogenesis
J Milutinovic, L C Agodoa, R E Cutler, et al.
The Journal of Antimicrobial Chemotherapy
|
November 1, 1982
Pharmacokinetics of ceftizoxime
R E Cutler, A D Blair, E D Burgess, et al.
Archives of Internal Medicine
|
March 1, 1971
Aminocaproic acid treatment of prolonged hematuria following renal biopsy
T A Haygood, R Atkins, J A Kennedy, et al.
Page
of 10